The secret ingredient behind the next revolution in medicine lies within each of us. Special cells in our bodies, called stem cells, have the ability to both extensively self-renew and, through a series of highly complex molecular events, turn themselves into all of the unique cells found in the human body. Scientists harnessing this remarkable latter ability, referred to as pluripotency, are using stem cells to repair or regenerate damaged tissues and organs, providing potential treatments for diseases such as Alzheimers and Parkinsons disease, diabetes, heart disease, stroke, arthritis, and cancer. In addition, stem cells can be used to create specialized tissues to test out drugs before prescribing them to humans.
Scientists are also using stem cells to learn how the human body is made and why some cells develop abnormally and lead to problems such as birth defects and cancer. Because stem cells eventually differentiate into mature cells that have specific jobs to do, they are actually quite rare in adults, meaning that the stem cells that scientists and clinicians work with are often donated from embryos. Therefore, another intense aspect of investigation is learning how to derive fully functional stem cells from adult cells.
The University of Maryland School of Medicine has quickly become a leader in the field of stem cell research. The Center for Stem Cell Biology and Regenerative Medicine opened in 2009 with the recruitment of Curt I. Civin, M.D., as its founding director. The mission of the Center is to bring together the scientific and clinical expertise necessary to discover how stem cells work and translate that knowledge into therapies for a wide variety of human diseases.
The Center is working towards several specific goals: developing a highly collaborative and interdisciplinary research environment; encouraging rapid translation of discoveries into innovative and practical clinical applications that will enhance the understanding, diagnosis, treatment, and prevention of human diseases; collaborating with pharmaceutical and biotechnology companies to stimulate investment and local economic growth; educating the local community about stem cell research; and advocating for the State of Marylands continuing support of stem cell research.
Capabilities
The Center operates two collaborative activities that act in tandem to fuel stem cell research by enhancing stem cell production and facilitating their transition into numerous cell types.
The first collaborative activity grows a variety of stem cells from multiple species, particularly embryonic stem cells and induced pluripotent stem cells, which are cells that can be genetically reprogrammed to behave like embryonic stem cells. Scientists from the University of Maryland, the National Institutes of Health, other universities and a myriad of biotechnology companies, will be able to expedite their research through access to the stem cells grown by this collaboration.
In our bodies, stem cells are very, very rare, says Civin. When we take them out and try to grow them in dishes, they prefer to die. Their second preference is to differentiate so theyre no longer stem cells. If theyre going to be used as therapeutic cells, or even used for research, wed like to be able to grow up lots and lots of them.
In the second collaborative activity, stem cells are modified genetically, providing scientists models for many different diseases. Cells are engineered to increase or decrease their production of certain molecules, a painstaking process that enables detailed mechanistic studies of cell function.
Researchers
More than 70 faculty scientists and physicians at University of Maryland contribute to the achievement of the Centers goals. In addition to the University of Maryland School of Medicine, members of the Center are affiliated with special laboratories, programs, and schools throughout the University of Maryland system. Faculty members are split into four Working Groups:
Scientific Highlights
Dr. Sunjay Kaushal uses stem cells removed during heart reconstruction surgery in children to treat patients who have suffered heart attacks, heart failure and congenital heart disease.
Dr. Ricardo Feldman is working to generate patient-specific induced pluripotent stem cells (iPSCs) for modeling and treating Gauchers disease, Parkinsons disease, and other neurodegenerative diseases.
Dr. Curt Civin is using next-generation gene editing in an effort to discover a cure for sickle cell anemiaone of the most common genetically inheritable diseases.
Collaborations
The Center has struck up a collaborative agreement between Maryland and California, two states at the forefront of stem cell research, to pool resources to help scientists in both states share their talents and discoveries.
The Center also collaborates closely with local biotechnology companies, such as Paragon Bioservices, Inc., one of the largest companies in the University of Marylands BioPark. Paragon worked with the Center to facilitate the research, commercial development and clinical application of stem cell-based technologies and therapies.
Weve been pushing the envelope on interacting with industry, says Civin. We go first to Maryland companies. We can go out and visit them, instead of just emailing and talking long distance about the process. Then we can do the first few experiments together in person to make sure were doing things right from the start.
View original post here:
Excellence in Stem Cell Research | University of Maryland ...
- Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement - Business Wire - October 13th, 2022
- Johns Hopkins Scientists Have Developed a Nanobody That May Treat Parkinson's Disease - SciTechDaily - September 25th, 2022
- UMD students contribute to tech, health fields with summer research projects - The Diamondback - September 16th, 2022
- Pair of Hopkins teams receive $200K in technology grants - Maryland Daily Record - August 22nd, 2022
- RoosterBio and AGC Biologics team up to accelerate manufacture of cell and exosome therapies - BioPharma-Reporter.com - August 22nd, 2022
- Stem Cell Transplant Reverses Sickle Cell Disease in Adults - July 3rd, 2022
- LONGEVERON INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - May 15th, 2022
- Top Ways To Rejuvenate Your Body And Improve Your Well-being - The Southern Maryland Chronicle - April 19th, 2022
- BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress... - April 19th, 2022
- Synthetic biology's past, present and future explored in timely new account - Winnipeg Free Press - April 6th, 2022
- US is Out of Step on Primate Research With Rest of World - NewsClick - October 5th, 2021
- A Look Inside A Termite's Gut Wins The 11th Annual Nikon Small World in Motion Competition - PRNewswire - August 18th, 2021
- What really happened in Wuhan? - The Sunday Guardian Live - The Sunday Guardian - June 6th, 2021
- UMD Researchers Perform Crucial Proof-of-Concept ... - December 20th, 2020
- US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use - USA TODAY - December 20th, 2020
- Sirnaomics to Initiate Phase I Study of STP705 in Treatment of Primary and Metastatic Liver Cancer | DNA RNA and Cells | News Channels -... - December 7th, 2020
- Trump was one of the first 10 patients to get an experimental COVID-19 treatment under special use - Yahoo News - October 8th, 2020
- New toilet, a VR camera and science experiments are heading to t - KAKE - October 8th, 2020
- ShoreRivers awarded DNR grant for two restoration projects - MyEasternShoreMD - August 26th, 2020
- CRISPR cows could boost sustainable meat production, but regulations and wary consumers stand in the way - Genetic Literacy Project - August 26th, 2020
- Over $8M in 2020 Stem Cell Funding Awards Continue to Fuel Marylands Leading Cell Therapy Industry - BioBuzz - June 24th, 2020
- Researchers develop nanoengineered bioink to 3D print functional bone tissue - 3D Printing Industry - May 27th, 2020
- 'Virus Goes In, Virus Goes Out': Advocates Call For Release Of More Low-Level Prisoners To Stem Infection Rate - Kaiser Health News - May 22nd, 2020
- What Do New Neurons in the Brains of Adults Actually Do? - The Scientist - May 7th, 2020
- David C. Karli is Offering a New Ray of Hope Through Regenerative Medicine - RESPECT. - May 3rd, 2020
- Could Innate Immunology Save Us From the Coronavirus? - The New York Times - May 3rd, 2020
- Watch: Hogan orders closure of bars, restaurants, theaters and gyms, restricts gatherings - Maryland Daily Record - March 22nd, 2020
- Dr Borehams Crucible: The small cap biotechs trying to make a buck from coronavirus - Stockhead - March 9th, 2020
- The Aussie Biotech Companies Trying To Make A Buck From Coronavirus - D'Marge - March 9th, 2020
- Organoids, iPSCs, and advanced cell models: Advancing discovery from basic research to drug discovery - Science Magazine - March 4th, 2020
- Maryland Stem Cell Center Consortium & Core Facility ... - March 4th, 2020
- Serving those who serve - The Hub at Johns Hopkins - November 14th, 2019
- BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic... - November 6th, 2019
- VetStem Biopharma Shares the Success Story of Ole who was Treated with VetStem Cell Therapy by Dr. Holly Mullen - PR Web - November 6th, 2019
- Contrasting of Applied Therapeutics Inc. (APLT) and Neuralstem Inc. (NASDAQ:CUR) - MS Wkly - November 6th, 2019
- Reviewing Synthetic Biologics Inc. (SYN)'s and Asterias Biotherapeutics Inc. (:)'s results - FinanceMercury - November 6th, 2019
- Comparing of Neuralstem Inc. (CUR) and Allakos Inc. (NASDAQ:ALLK) - MS Wkly - November 6th, 2019
- Head-To-Head Survey: Intrexon (NASDAQ:XON) versus US Stem Cell (NASDAQ:USRM) - Riverton Roll - September 25th, 2019
- Analyzing US Stem Cell (OTCMKTS:USRM) and Intrexon (OTCMKTS:XON) - TechNewsObserver - September 25th, 2019
- Reviewing Intrexon (NASDAQ:XON) & US Stem Cell (NASDAQ:USRM) - Mayfield Recorder - September 25th, 2019
- Artificially Engineering Intestine - Mirage News - September 25th, 2019
- Prothena Corporation plc (PRTA)'s Financial Results Comparing With Neuralstem Inc. (NASDAQ:CUR) - The EN Herald - September 25th, 2019
- cord_blood - Maryland - September 14th, 2019
- Stem Cells and Type 1 Diabetes: What the Future Has in ... - April 24th, 2019
- Stem Cell Therapy in Maryland | Stem Cell Professionals - April 5th, 2019
- Meristem - Wikipedia - January 17th, 2019
- Stem Cell Therapy in Annapolis Maryland | Stem Cell ... - October 25th, 2018
- Stem Cell Centers - Towson > Stem Cell Centers - October 6th, 2018
- STEM CELL THERAPY - Orthopedic and Wellness Maryland - September 5th, 2018
- Patient Resources | University of Maryland School of Medicine - September 5th, 2018
- Stem Cell Clinical Trial | University of Maryland Children ... - August 17th, 2018
- Baltimore, Maryland Stem Cell Transplants, Montgomery ... - August 17th, 2018
- Nervous System Stem Cells Can Replace Themselves, Give ... - July 3rd, 2018
- Maryland Stem Cell Research Fund: 2014 Awardees - June 24th, 2018
- Catholic response to stem cells - Featured Today ... - October 14th, 2017
- Free stem cell Essays and Papers - 123HelpMe - October 12th, 2017
- How Stem Cell Therapy Can Help Repair and Regenerate Your Body - October 12th, 2017
- How Stem Cell Therapy Can Help Repair and ... - Mercola.com - September 4th, 2017
- Science and technology to get boost from CRS-12 mission - SpaceFlight Insider - August 12th, 2017
- Cannon Scholars visit National Institute of Standards and Technology - Dover Post - August 9th, 2017
- Lab-Grown, Virus-Free Stem Cells Repair Retinal Tissue in ... - August 9th, 2017
- Roanoke researchers pursue treatments for the type of deadly brain cancer affecting McCain - Roanoke Times - August 3rd, 2017
- The Maryland Stem Cell Research Fund (MSCRF) | Tedco - November 25th, 2016
- Center for Stem Cell Biology & Regenerative Medicine ... - November 14th, 2016
- Ginger | University of Maryland Medical Center - September 6th, 2016
- Johns Hopkins Team Creates Stem Cells From Schizophrenia ... - September 5th, 2016
- Human Induced Pluripotent Stem Cell Derived Neuronal Cells ... - August 18th, 2016
- Maryland Stem Cell Center Consortium and Core Facility ... - August 12th, 2016
- Human Stem Cells Institute - Wikipedia, the free encyclopedia - October 19th, 2015
- Patients' Own Genetically Altered Immune Cells Show ... - October 19th, 2015
- Maryland Stem Cell Research Fund: Funding Opportunities - July 2nd, 2015
- MRI based on a sugar molecule can tell cancerous from noncancerous cells - March 27th, 2015
- MD Stem Cells Release Optic Nerve Vision Loss Reversed ... - March 22nd, 2015
- TiGenix: TiGenix reports its full year 2014 results - March 18th, 2015
- Gene regulatory path revealed as target for therapy of aggressive pediatric brain cancer - March 10th, 2015
- American Spine offers experimental fix for pain -- Gazette.Net - January 28th, 2015
- American Spine offers experimental fix for pain - January 28th, 2015
- Toughest Breast Cancer May Have Met Its Match - December 9th, 2014
- Bid on Stem Cells and Alcohol-induced Tissue Injuries (R21 ... - November 12th, 2014
- Head, National Institutes of Health Stem Cell Technology ... - November 11th, 2014